Banner Publications MH200828 N141

Publications

Results found: 80

Showing results: 51 - 80

Journal of cellular and molecular medicine

Identification of F-box only protein 7 as a negative regulator of NF-kappaB signalling.

01-09-2012
Nature

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

26-01-2012
The Journal of experimental medicine

A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation.

19-12-2011
PloS one

The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence.

08-10-2011
Cancer discovery

Functional subtyping of breast cancer.

01-08-2011
Cell

A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation.

15-04-2011
Cell cycle (Georgetown, Tex.)

Screening for modulators of cisplatin sensitivity: unbiased screens reveal common themes.

01-02-2011
IDrugs : the investigational drugs journal

Using large-scale RNAi screens to identify novel drug targets for cancer.

01-11-2010
Future oncology (London, England)

Exploration of synthetic lethal interactions as cancer drug targets.

01-11-2010
Molecular cancer research : MCR

Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade.

01-04-2010
Clinical cancer research : an official journal of the American Association for Cancer Research

Candidate biomarkers of response to an experimental cancer drug identified through a large-scale RNA interference genetic screen.

15-09-2009
Cancer cell

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.

07-04-2009
PloS one

A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway.

12-03-2009
Nature

Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1.

29-11-2007
Cancer cell

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

01-10-2007
The Journal of biological chemistry

Telomerase-independent regulation of ATR by human telomerase RNA.

29-12-2006
Nature methods

shRNA libraries and their use in cancer genetics.

01-09-2006
Nature chemical biology

An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors.

01-04-2006
Cold Spring Harbor symposia on quantitative biology

Functional identification of cancer-relevant genes through large-scale RNA interference screens in mammalian cells.

25-08-2005
Cell

A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity.

17-06-2005
Nature

A large-scale RNAi screen in human cells identifies new components of the p53 pathway.

25-03-2004
Genes & development

Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.

01-12-1996
Biochimica et biophysica acta

Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins.

07-06-1996
The Journal of biological chemistry

Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.

08-03-1996
Genes & development

Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.

01-06-1995
Molecular and cellular biology

E2F-5, a new E2F family member that interacts with p130 in vivo.

01-06-1995
Genes & development

E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.

15-11-1994
The EMBO journal

Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.

01-09-1994
The Journal of biological chemistry

Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase.

05-08-1993
FEBS letters

Cloning, expression and chromosomal localization of a new putative receptor-like protein tyrosine phosphatase.

23-09-1991

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.